A new case of "de novo" BRCA1 mutation in a patient with early-onset breast cancer
- PMID: 28265380
- PMCID: PMC5331191
- DOI: 10.1002/ccr3.718
A new case of "de novo" BRCA1 mutation in a patient with early-onset breast cancer
Abstract
Most of the de novo BRCA1/2 mutations have been identified in patients with early-onset breast cancer and without family history of the disease. The identification of these alterations could play a prominent role in the prevention and treatment strategies and may influence clinical management of patients.
Keywords: BRCA2 gene; breast cancer; de novo mutation; early onset.
Figures
Similar articles
-
Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing.Breast Cancer Res Treat. 2012 Feb;132(1):87-95. doi: 10.1007/s10549-011-1544-9. Epub 2011 May 7. Breast Cancer Res Treat. 2012. PMID: 21553119
-
De novo recurrent germline mutation of the BRCA2 gene in a patient with early onset breast cancer.J Med Genet. 2001 Feb;38(2):102-5. doi: 10.1136/jmg.38.2.102. J Med Genet. 2001. PMID: 11158174 Free PMC article.
-
Case report: de novo BRCA2 gene mutation in a 35-year-old woman with breast cancer.Clin Genet. 2009 Nov;76(5):427-30. doi: 10.1111/j.1399-0004.2009.01246.x. Epub 2009 Oct 1. Clin Genet. 2009. PMID: 19796187
-
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations.Oncogene. 2016 Mar 10;35(10):1324-7. doi: 10.1038/onc.2015.181. Epub 2015 Jun 1. Oncogene. 2016. PMID: 26028024
-
Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.BMC Med Genet. 2006 Oct 4;7:75. doi: 10.1186/1471-2350-7-75. BMC Med Genet. 2006. PMID: 17018160 Free PMC article.
Cited by
-
Novel De Novo BRCA2 Variant in an Early-Onset Ovarian Cancer Reveals a Unique Tumor Evolution Pathway.Int J Mol Sci. 2025 Mar 5;26(5):2295. doi: 10.3390/ijms26052295. Int J Mol Sci. 2025. PMID: 40076915 Free PMC article.
-
Detection of Germline Mutations in a Cohort of 250 Relatives of Mutation Carriers in Multigene Panel: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2.Cancers (Basel). 2023 Dec 6;15(24):5730. doi: 10.3390/cancers15245730. Cancers (Basel). 2023. PMID: 38136276 Free PMC article.
-
A Novel BRCA1 Gene Mutation Detected With Breast Cancer in a Vietnamese Family by Targeted Next-Generation Sequencing: A Case Report.Breast Cancer (Auckl). 2020 Jan 17;14:1178223420901555. doi: 10.1177/1178223420901555. eCollection 2020. Breast Cancer (Auckl). 2020. PMID: 32009791 Free PMC article.
-
Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).BMC Cancer. 2020 Aug 10;20(1):747. doi: 10.1186/s12885-020-07250-0. BMC Cancer. 2020. PMID: 32778078 Free PMC article.
-
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.Int J Mol Sci. 2017 Jul 21;18(7):1586. doi: 10.3390/ijms18071586. Int J Mol Sci. 2017. PMID: 28754000 Free PMC article. Review.
References
-
- Edwards, E. , Yearwood C., Sillibourne J., Baralle D., and Eccles D.. 2009. Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer. Fam. Cancer 8:479–482. - PubMed
-
- Golmard, L. , Delnatte C., Laugé A., Moncoutier V., Lefol C., Abidallah K., et al. 2015. Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations. Oncogene 35:1324–1327. - PubMed
-
- Marshall, M. , Solomon S., and Lawrence Wickerham D.. 2009. Case report: de novo BRCA2 gene mutation in a 35‐year‐old woman with breast cancer. Clin. Genet. 76:427–430. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous